Phenyl derivatives as factor XA inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S310000, C514S312000, C514S313000, C346S150300, C346S150300, C346S150300, C346S141000, C346S141000, C346S106000

Reexamination Certificate

active

07902223

ABSTRACT:
Novel compounds of the formula (I), in which D, W, X, Y, T and R1are as defined in Patent Claim1, are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumors.

REFERENCES:
patent: 3279880 (1966-10-01), Straley et al.
patent: 28 15 820 (1978-10-01), None
patent: 00 71508 (2000-11-01), None
patent: 00 71510 (2000-11-01), None
patent: 00 71511 (2000-11-01), None
patent: 02 057236 (2002-07-01), None
Freshney, R. Ian, Culture of Animal Cells: A manuel of Basis Technique, New York, pp. 4-6, 2000.
Dermer, Gerald B., “Another Anniversary for the War on Cancer”, Bio/technology, vol. 12, p. 320, Mar. 1994.
L. Desaubry et al., “Synthesis of a Conformationally . . . Adenine Derivative”,Tetrahedron Letters, 36(24), pp. 4249-4252 (1995).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Phenyl derivatives as factor XA inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phenyl derivatives as factor XA inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenyl derivatives as factor XA inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2720164

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.